Cibc Private Wealth Group, LLC Immatics N.V. Transaction History
Cibc Private Wealth Group, LLC
- $51.4 Billion
- Q2 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Immatics N.V. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 27 shares of IMTX stock, worth $342. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27Holding current value
$342% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMTX
# of Institutions
99Shares Held
76.6MCall Options Held
571KPut Options Held
210K-
Rtw Investments, LP New York, NY10MShares$127 Million1.94% of portfolio
-
Wellington Management Group LLP Boston, MA9.54MShares$121 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$103 Million2.72% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.43MShares$94.3 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$81.7 Million1.0% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $967M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...